These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17201125)

  • 1. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2006; 26(6B):4143-8. PubMed ID: 17201125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2006; 26(5A):3217-22. PubMed ID: 17094432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
    Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2007; 27(6B):3813-8. PubMed ID: 18225537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
    Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
    Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
    Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
    Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.
    Bell EN; Tse MY; Frederiksen LJ; Gardhouse A; Pang SC; Graham CH; Siemens DR
    J Urol; 2007 Feb; 177(2):751-6. PubMed ID: 17222675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approach for cancer using four cardiovascular hormones.
    Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
    Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides up-regulate aquaporin 3 in a human colonic epithelial cell line.
    Itoh A; Tsujikawa T; Yasuoka T; Nakahara T; Sasaki M; Fujiyama Y
    Int J Mol Med; 2004 Oct; 14(4):621-6. PubMed ID: 15375592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
    Vesely DL; Perez-Lamboy GI; Schocken DD
    Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells.
    Borán MS; Baltrons MA; García A
    Glia; 2008 Mar; 56(4):394-411. PubMed ID: 18186083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
    Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
    Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
    Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
    In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
    Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
    Sun Y; Eichelbaum EJ; Lenz A; Wang H; Vesely DL
    Eur J Clin Invest; 2010 May; 40(5):408-13. PubMed ID: 20353436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.